Trou­bled MiMedx ax­es a quar­ter of its work­force in the wake of a C-suite purge

Re­mem­ber when MiMedx $MXDG got rid of its CEO and COO to pre­pare the com­pa­ny “for its next chap­ter”? The trou­bled biotech now says that 240 of its full-time em­ploy­ees will be left out of that chap­ter.

The lay­offs, which ac­count for 24% of MiMedx’s to­tal work­force, are part of a sweep­ing re­or­ga­ni­za­tion with the aim of slim­ming down its cost struc­ture to stay afloat.

MiMedx’s woes first came un­der the spot­light in Feb­ru­ary, weeks af­ter the FBI showed up at the door of a short sell­er who’s been hurl­ing in­sults against the com­pa­ny and its ex-CEO, Park­er “Pe­te” Pe­tit. The short sell­er, Marc Co­hodes, made a com­plaint to the De­part­ment of Jus­tice.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER